UK reviews ACT (autologous cartilage transplantation) for major knee cartilage defects
This article was originally published in Clinica
Executive Summary
The UK's Department of Health has launched a review of its policy on the use of autologous cartilage transplantation (ACT) for the treatment of clinically significant ("full-thickness") cartilage defects in knee joints. The health technology assessment (HTA) report is due to be published in mid-2005.
You may also be interested in...
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.
Pipeline Watch: Five Approvals And 23 Phase III Updates
Pipeline Watch is a weekly snapshot of selected late-stage clinical trial events and approvals announced by pharmaceutical and biotech companies at medical and industry conferences, in financial and company presentations, and in company releases and statements.